A Randomized Multicenter Phase II Study Of Induction Therapy With Pemetrexed And Cisplatin Followed By Chemoradiation With Pemetrexed Versus Chemoradiation With Pemetrexed Followed By Consolidation Therapy With Pemetrexed And Cisplatin In Patients With Stage III Non-Small Cell Lung Cancer: Paccora Trial
Interventional
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Response rate
after each treatment modality and 5 year follow-up
No
Paul R Germonpre, MD PhD
Principal Investigator
Thoracic Oncology Group Antwerp
Belgium: The Federal Public Service (FPS) Health, Food Chain Safety and Environment
TOGA 0502
NCT00497315
February 2006
March 2009
Name | Location |
---|